Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AdaptHealth (AHCO) Income from Non-Controlling Interests (2019 - 2026)

AdaptHealth has reported Income from Non-Controlling Interests over the past 7 years, most recently at $1.2 million for Q4 2025.

  • For Q4 2025, Income from Non-Controlling Interests rose 8.06% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $4.8 million, up 9.13%, while the annual FY2025 figure was $4.8 million, 9.13% up from the prior year.
  • Income from Non-Controlling Interests for Q4 2025 was $1.2 million at AdaptHealth, down from $1.2 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $1.2 million in Q3 2025 and troughed at $174000.0 in Q3 2021.
  • A 5-year average of $951200.0 and a median of $1.1 million in 2023 define the central range for Income from Non-Controlling Interests.
  • Biggest five-year swings in Income from Non-Controlling Interests: crashed 71.93% in 2021 and later soared 535.06% in 2022.
  • Year by year, Income from Non-Controlling Interests stood at $529000.0 in 2021, then soared by 92.25% to $1.0 million in 2022, then fell by 8.75% to $928000.0 in 2023, then rose by 22.95% to $1.1 million in 2024, then rose by 8.06% to $1.2 million in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for AHCO at $1.2 million in Q4 2025, $1.2 million in Q3 2025, and $1.2 million in Q2 2025.